Cargando…
The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high cardiovascular disease (CVD) risk. DESIGN: Two cohort studies including the general population and initiators of statins aged 35–74 years. SETTING: UK primary care records in the Clinical Practice Resear...
Autores principales: | van Staa, Tjeerd-Pieter, Smeeth, Liam, Ng, Edmond S-W, Goldacre, Ben, Gulliford, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812879/ https://www.ncbi.nlm.nih.gov/pubmed/23735939 http://dx.doi.org/10.1136/heartjnl-2013-303698 |
Ejemplares similares
-
Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk?
por: van Staa, Tjeerd-Pieter, et al.
Publicado: (2014) -
Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
por: Matthews, Anthony, et al.
Publicado: (2016) -
Randomised Evaluations of Accepted Choices in Treatment (REACT) trials: large-scale pragmatic trials within databases of routinely collected electronic healthcare records
por: van Staa, Tjeerd-Pieter, et al.
Publicado: (2011) -
Pragmatic randomised trials using routine electronic health records: putting them to the test
por: van Staa, Tjeerd-Pieter, et al.
Publicado: (2012) -
Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data
por: Goldacre, Ben, et al.
Publicado: (2019)